Ovid Therapeutics Inc — Cash Flow (NASDAQ:OVID) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 51.58 M118.6 M55.2 M45.8 M56 M 37.95 M Cash from investing activities 34.65 M-1.82 M-87.88 M-2.58 M54.59 M 43.5 M Cash from financing activities 47.07 M904.08 K180.66 K30.54 M622 K 28 K Free cash flow 51.19 M118.41 M53.78 M45.66 M55.84 M 37.93 M

新闻

PTC Therapeutics (PTCT) Reports Q4 Loss, Misses Revenue Estimates

Ovid Therapeutics: Bullish Post-PIPE With Two Differentiated CNS Moonshots

Ovid’s KCC2 activator shows promising safety in early trial

Ovid Therapeutics股东批准增加授权股份及相关提案

Ovid Therapeutics shareholders approve increase in authorized shares and related proposals

Roth/MKM 给予 Ovid Therapeutics 股票"买入"评级，看好其癫痫药物

Roth/MKM initiates Ovid Therapeutics stock with Buy rating on epilepsy drug

Ovid Therapeutics任命Petra Kaufmann为首席医疗官

Ovid Therapeutics appoints Petra Kaufmann as chief medical officer

This Alto Neuroscience Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Adverum Biotechnologies (NASDAQ:ADVM), Alto Neuroscience (NYSE:ANRO)

Ovid TherapeuticsQ3每股收益及营收逊于预期

Ovid Therapeutics earnings missed by $0.02, revenue fell short of estimates